"synopsis" may belong to another edition of this title.
Book Description Paperback or Softback. Condition: New. Ulcerative colitis 0.37. Book. Seller Inventory # BBS-9783659622175
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020296591
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783659622175_lsuk
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659622175
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783659622175
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Ulcerative Colitis and Crohn's disease are the two main types of inflammatory bowel disease. Treatment of ulcerative colitis is associated with improvement in symptoms, endoscopic appearance and histology. Treatment of ulcerative colitis has traditionally been targeted at control of symptoms and clinical remission. However, evidence suggests that only symptom control may be insufficient to achieve long-term outcome. Mucosal healing as treatment outcome has shown promising results in recent studies. Repeated assessment of mucosal healing requires repeated endoscopic procedures and may impose problems with added cost, complications associated with endoscopic procedures and patient acceptance. Non-invasive tests or surrogate markers may help clinicians to predict mucosal healing without the inconvenience of repeated endoscopic examinations. The ideal marker should be non-invasive, acceptable to patients, easily available and should have good sensitivity as well as specificity to detect severity of colonic inflammation. The present study aimed to find out the correlation of fecal biomarkers with mucosal healing in ulcerative colitis patients. 108 pp. Englisch. Seller Inventory # 9783659622175
Book Description PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659622175
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Ulcerative Colitis and Crohn's disease are the two main types of inflammatory bowel disease. Treatment of ulcerative colitis is associated with improvement in symptoms, endoscopic appearance and histology. Treatment of ulcerative colitis has traditionally been targeted at control of symptoms and clinical remission. However, evidence suggests that only symptom control may be insufficient to achieve long-term outcome. Mucosal healing as treatment outcome has shown promising results in recent studies. Repeated assessment of mucosal healing requires repeated endoscopic procedures and may impose problems with added cost, complications associated with endoscopic procedures and patient acceptance. Non-invasive tests or surrogate markers may help clinicians to predict mucosal healing without the inconvenience of repeated endoscopic examinations. The ideal marker should be non-invasive, acceptable to patients, easily available and should have good sensitivity as well as specificity to detect severity of colonic inflammation. The present study aimed to find out the correlation of fecal biomarkers with mucosal healing in ulcerative colitis patients. Seller Inventory # 9783659622175
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Thakur Manik LalM.L. Thakur, DM, Senior Resident S.K. Sinha, DM, Additional Professor K.K. Prasad, MD, PDCC, CFN, FICPath: Additional Professor C. Vaishnavi, MD, Professor R. Kochhar, DM, Professor: Department of Superspeciality . Seller Inventory # 5169024